Axsome Therapeutics : Change in Certifying Accountants : vim

8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549



FORM 8-K



CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193...

Related Keywords

New York , United States , Washington , Delaware , Herriot Tabuteau , Commission File Number , Axsome Therapeutics Inc , Securities Exchange , Ernst Young , Previous Independent Registered Public Accounting Firm , Exchange Commission , Public Accounting Firm , Deloitte Touche , Deloitte , During The Company , World Trade Center , Securities Exchange Act , Its Charter , Principal Executive Offices , Zip Code , Telephone Number , Including Area Code , Former Name , Former Address , Changed Since Last Report , Securities Act , Exchange Act , Par Value , New Independent Registered Public Accounting , Audit Committee , Axsome Therapeutics , Current Report , Regulations K , Previous Independent Registered Public Accounting , United States Securities , Page Interactive Data File , Chief Executive , Markets ,